Unlock your academic potential and expand your network by joining us!

Shaker A Mousa

Prof. Shaker A Mousa

Albany College of Pharmacy and Health Sciences
+ 1

Share Link

Share

Information

Dr Mousa is a tenured professor of Pharmacology at the Albany College of Pharmacy, Executive VP, Vice Provost and chair of PRI at Albany, NY. Dr. Mousa is founder of the Pharmaceutical Research Institute, started in 2002, and founder of several spin-off pharmaceutical and biotechnology companies. He has held a senior, principal research scientist and research fellowship at DuPont Pharmaceuticals and Imaging Co., DuPont Merck and DuPont Pharmaceuticals Company for two decades. He was awarded the 2017 Kuwait Foundation for Advancement in Sciences (KFAS) Laureate for Applied Sciences in Medicine, the 2018 Fellow of the National Academy of Inventors (FNAI) and, in 2020, the first Sheikh Zayed International Award in Traditional Complementary and Alternative Medicine (TCAM) in Prophetic Medicines for improved human health and quality of life. Among Dr. Mousa’s professional accomplishments are his contributions to several patents and to the discovery and development of novel anti-platelet, anti-thrombotic therapies, non-invasive myocardial perfusion and thrombus imaging agents. His work is reported in over 1000 peer-reviewed publications and holds over 400 US Patents and International Patents.

Research Keywords & Expertise

Biotechnology
Hematology
Nanotechnology
Pharmacology
Vascular

Fingerprints

14%
Vascular
7%
Pharmacology
6%
Nanotechnology
5%
Biotechnology
5%
Hematology
5%
Cardiovascular and cerebrovascular diseases

Short Biography

Dr Mousa is a tenured professor of Pharmacology at the Albany College of Pharmacy, Executive VP, Vice Provost and chair of PRI at Albany, NY. Dr. Mousa is founder of the Pharmaceutical Research Institute, started in 2002, and founder of several spin-off pharmaceutical and biotechnology companies. He has held a senior, principal research scientist and research fellowship at DuPont Pharmaceuticals and Imaging Co., DuPont Merck and DuPont Pharmaceuticals Company for two decades. He was awarded the 2017 Kuwait Foundation for Advancement in Sciences (KFAS) Laureate for Applied Sciences in Medicine, the 2018 Fellow of the National Academy of Inventors (FNAI) and, in 2020, the first Sheikh Zayed International Award in Traditional Complementary and Alternative Medicine (TCAM) in Prophetic Medicines for improved human health and quality of life. Among Dr. Mousa’s professional accomplishments are his contributions to several patents and to the discovery and development of novel anti-platelet, anti-thrombotic therapies, non-invasive myocardial perfusion and thrombus imaging agents. His work is reported in over 1000 peer-reviewed publications and holds over 400 US Patents and International Patents.